Life Healthcare Group Holdings Limited (LHC.JO)
ZAc 1444.0
(-0.48%)
ZAc 1444.0
(-0.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.59 Billion ZAR | -23.11% |
| 2022 | 3.51 Billion ZAR | -3.21% |
| 2021 | 5.06 Billion ZAR | 19.07% |
| 2020 | 4.16 Billion ZAR | -22.73% |
| 2019 | 6.44 Billion ZAR | 8.4% |
| 2018 | 5.58 Billion ZAR | 1.4% |
| 2017 | 4.65 Billion ZAR | 18.36% |
| 2016 | 4.04 Billion ZAR | 7.21% |
| 2015 | 4.11 Billion ZAR | 9.05% |
| 2014 | 4.64 Billion ZAR | 19.68% |
| 2013 | 3.38 Billion ZAR | 15.71% |
| 2012 | 2.61 Billion ZAR | -7.0% |
| 2011 | 2.62 Billion ZAR | 18.84% |
| 2010 | 2.26 Billion ZAR | 18.33% |
| 2009 | 1.99 Billion ZAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 856.5 Million ZAR | -25.2% |
| 2024 Q2 | 856.5 Million ZAR | 118.1% |
| 2023 FY | - ZAR | -23.11% |
| 2023 Q4 | -240 Million ZAR | 0.0% |
| 2023 Q2 | 2.59 Billion ZAR | 191.94% |
| 2023 Q1 | 887.5 Million ZAR | -63.22% |
| 2022 Q2 | 2.25 Billion ZAR | 89.19% |
| 2022 Q1 | 1.19 Billion ZAR | -55.25% |
| 2022 FY | - ZAR | -3.21% |
| 2022 Q4 | 2.41 Billion ZAR | 124.05% |
| 2022 Q3 | 1.07 Billion ZAR | -52.28% |
| 2021 Q2 | 2.41 Billion ZAR | 116.47% |
| 2021 Q3 | 1.28 Billion ZAR | -46.92% |
| 2021 Q4 | 2.66 Billion ZAR | 107.71% |
| 2021 FY | - ZAR | 19.07% |
| 2021 Q1 | 1.11 Billion ZAR | -23.23% |
| 2020 Q3 | 496.5 Million ZAR | -83.01% |
| 2020 Q4 | 1.45 Billion ZAR | 193.05% |
| 2020 Q1 | 1.44 Billion ZAR | -52.49% |
| 2020 Q2 | 2.92 Billion ZAR | 102.85% |
| 2020 FY | - ZAR | -22.73% |
| 2019 Q1 | 1.36 Billion ZAR | -4.0% |
| 2019 Q3 | 1.48 Billion ZAR | 8.71% |
| 2019 Q2 | 1.36 Billion ZAR | 0.0% |
| 2019 Q4 | 3.03 Billion ZAR | 104.17% |
| 2019 FY | - ZAR | 8.4% |
| 2018 Q2 | 1.33 Billion ZAR | 0.0% |
| 2018 FY | - ZAR | 1.4% |
| 2018 Q4 | 1.42 Billion ZAR | 0.0% |
| 2018 Q3 | 1.42 Billion ZAR | 6.51% |
| 2018 Q1 | 1.33 Billion ZAR | 4.21% |
| 2017 FY | - ZAR | 18.36% |
| 2017 Q1 | 1.2 Billion ZAR | 9.86% |
| 2017 Q4 | 1.28 Billion ZAR | 0.0% |
| 2017 Q3 | 1.28 Billion ZAR | 6.08% |
| 2017 Q2 | 1.2 Billion ZAR | 0.0% |
| 2016 Q1 | 1.05 Billion ZAR | -0.33% |
| 2016 FY | - ZAR | 7.21% |
| 2016 Q4 | 1.1 Billion ZAR | 0.0% |
| 2016 Q3 | 1.1 Billion ZAR | 4.12% |
| 2016 Q2 | 1.05 Billion ZAR | 0.0% |
| 2015 Q3 | 1.06 Billion ZAR | 9.5% |
| 2015 Q4 | 1.06 Billion ZAR | 0.0% |
| 2015 Q1 | 968.5 Million ZAR | 3.03% |
| 2015 FY | - ZAR | 9.05% |
| 2015 Q2 | 968.5 Million ZAR | 0.0% |
| 2014 Q3 | 940 Million ZAR | 8.17% |
| 2014 FY | - ZAR | 19.68% |
| 2014 Q4 | 940 Million ZAR | 0.0% |
| 2014 Q2 | 869 Million ZAR | 0.0% |
| 2014 Q1 | 869 Million ZAR | -3.44% |
| 2013 Q3 | 900 Million ZAR | 16.5% |
| 2013 FY | - ZAR | 15.71% |
| 2013 Q2 | 772.5 Million ZAR | 0.0% |
| 2013 Q4 | 900 Million ZAR | 0.0% |
| 2013 Q1 | 772.5 Million ZAR | -0.58% |
| 2012 Q4 | 777 Million ZAR | 0.0% |
| 2012 FY | - ZAR | -7.0% |
| 2012 Q3 | 777 Million ZAR | 29.5% |
| 2012 Q2 | 600 Million ZAR | -12.7% |
| 2012 Q1 | 687.29 Million ZAR | 0.0% |
| 2011 Q3 | 687.29 Million ZAR | 0.0% |
| 2011 Q1 | 591.94 Million ZAR | 0.0% |
| 2011 Q2 | 687.29 Million ZAR | 16.11% |
| 2011 Q4 | 687.29 Million ZAR | 0.0% |
| 2011 FY | - ZAR | 18.84% |
| 2010 Q4 | 591.94 Million ZAR | 0.0% |
| 2010 Q3 | 591.94 Million ZAR | 0.0% |
| 2010 Q2 | 591.94 Million ZAR | 18.88% |
| 2010 Q1 | 497.91 Million ZAR | 0.0% |
| 2010 FY | - ZAR | 18.33% |
| 2009 Q2 | 497.91 Million ZAR | 0.0% |
| 2009 Q4 | 497.91 Million ZAR | 0.0% |
| 2009 FY | - ZAR | 0.0% |
| 2009 Q3 | 497.91 Million ZAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|